 | Up a level |
Birkhäuser, Martin; Böttcher, Bettina; Germeyer, Ariane; Hadji, Peyman; Imthurn, Bruno; Mueck, Alfred O; Neulen, Joseph; Stute, Petra; Thaler, Christian J; Wiegratz, Inka; Wildt, Ludwig (2023). The risk of thromboembolism and use of combined oral contraceptives: a comment. BJOG : an international journal of obstetrics and gynaecology, 130(7), pp. 844-845. Wiley 10.1111/1471-0528.17434
Dhayat, Nasser; Marti, Nesa Magdalena; Kollmann, Zahraa; Bally, Lia; Escher, Geneviève; Grössl, Michael; Ackermann, Daniel; Mueller, Michael; Vogt, Bruno; Birkhäuser, Martin; Flück Pandey, Christa Emma (2018). Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites. PLoS ONE, 13(10), e0203903. Public Library of Science 10.1371/journal.pone.0203903
Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss medical weekly, 147(w14484), w14484. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14484
Nedeljkovic, Marko; Tian, Li; Ji, Ping; Déglon-Fischer, Agnès; Stute, Petra; Ocon, Erika; Birkhäuser, Martin; Ausfeld-Hafter, Brigitte (2013). Effects of acupuncture and Chinese herbal medicine (Zhi Mu 14) on hot flushes and quality of life in postmenopausal women: results of a four-arm randomized controlled pilot trial. Menopause - the journal of the North American Menopause Society, 21(1), pp. 15-24. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/GME.0b013e31829374e8
Birkhäuser, Martin (2013). Prevention of postmenopausal osteoporosis. Gynäkologische Endokrinologie, 11(4), pp. 289-298. Springer-Medizin-Verlag 10.1007/s10304-013-0551-9
Birkhäuser, Martin (2013). Prevention of postmenopausal osteoporosis. Gynäkologische Endokrinologie, 11(2), pp. 129-136. Springer-Medizin-Verlag 10.1007/s10304-013-0550-x
Birkhäuser, Martin (2013). Geriatric endocrinology. Gynäkologische Endokrinologie, 11(4), pp. 241-242. Springer-Medizin-Verlag 10.1007/s10304-013-0560-8
Lippuner, Kurt; Buchard, P A; De Geyter, C; Imthurn, B; Lamy, O; Litschgi, M; Luzuy, F; Schiessl, K; Stute, P; Birkhäuser, M (2012). Recommendations for raloxifene use in daily clinical practice in the Swiss setting. European spine journal, 21(12), pp. 2407-17. Berlin: Springer-Verlag 10.1007/s00586-012-2404-y
Birkhäuser, M; De Geyter, Ch; Finkenstedt, G; Hofbauer, L; Meier, C; Scharla, S; Stute, P; Ziller, V; Hadji, P (2012). Osteoporose: Phasengerechte Therapie & Neues aus der Zellbiologie. Journal für Mineralstoffwechsel : Zeitschrift für Knochen- und Gelenkserkrankunge, 19(1), pp. 42-6. Gablitz (A): Krause & Pachernegg
Birkhäuser, M; De Geyter, Ch; Finkenstedt, G; Hofbauer, L; Meier, C; Scharla, S; Stute, P; Ziller, V; Hadji, P (2012). Ostéoporose: traitements par stade & innovations en biologie cellulaire. Journal für gynäkologische Endokrinologie, 6(2), pp. 20-4. Gablitz (A): Krause & Pachernegg
Birkhäuser, M; De Geyter, Ch; Finkenstedt, G; Hofbauer, L; Meier, C; Scharla, S; Stute, P; Ziller, V; Hadji, P (2012). Osteoporose: Phasengerechte Therapie & Neues aus der Zellbiologie. Journal für gynäkologische Endokrinologie, 6(1), pp. 22-6. Gablitz (A): Krause & Pachernegg
Stute, P; Becker, HG; Birkhäuser, M; Bitzer, J; chatsiproios, D; Luzuy, F; von Wolff, M; Wunder, D (2012). Ultra-Low Dose – Neue Wege in der Hormontherapie. Journal für gynäkologische Endokrinologie, 6(3), pp. 20-3. Gablitz (A): Krause & Pachernegg
Birkhäuser, M; Stute, P (2011). Editorial. Journal für gynäkologische Endokrinologie - Schweiz, 5(1), pp. 5-10. Gablitz (A): Krause & Pachernegg
Hadji, P; Lippuner, K; Concin, H; Scharla, S; Birkhäuser, M; Fahrleitner-Pammer, A; Stute, P; Finkenstedt, G; Resch, H; Defèr, A; Minne, H-W; Ringe, J D; Dimai, H; Ziller, V (2011). Statement der trinationalen Expertenrunde Osteoporose. Die individualisierte Osteoporosebehandlung: Sequenztherapie und spezielle Patientengruppen. Journal für Mineralstoffwechsel : Zeitschrift für Knochen- und Gelenkserkrankunge, 18(1), pp. 48-55. Krause & Pachernegg
Birkhäuser, Martin (2010). Hormonal contraceptives of the second, third, and fourth generation. Gynäkologische Endokrinologie, 8(4), pp. 263-270. Springer-Medizin-Verlag 10.1007/s10304-010-0384-8
Birkäuser, M. (2010). Depression and estrogens. Gynäkologische Endokrinologie, 8(1), pp. 82-88. Springer-Medizin-Verlag 10.1007/s10304-009-0317-6
Birkhäuser, Martin (2010). On the situation of the three pillars of gynaecology. Gynäkologische Endokrinologie, 8(4), pp. 286-290. Springer-Medizin-Verlag 10.1007/s10304-010-0383-9
Kuhn, Annette; Bodmer, Christine; Stadlmayr, Werner; Kuhn, Peter; Mueller, Michael D; Birkhäuser, Martin (2009). Quality of life 15 years after sex reassignment surgery for transsexualism. Fertility and sterility, 92(5), 1685-1689.e3. New York, N.Y.: Elsevier 10.1016/j.fertnstert.2008.08.126
Riecher-Rössler, A.; Schmid, C.; Bleuer, S.; Birkhäuser, M. (2009). Antipsychotics and hyperprolactinaemia: pathophysiology, clinical significance, clarification and therapy. Gynäkologische Endokrinologie, 7(3), pp. 171-182. Springer-Medizin-Verlag 10.1007/s10304-009-0316-7
Bersinger, Nick A; Wunder, Dorothea M; Birkhäuser, Martin H; Mueller, Michael D (2008). Gene expression in cultured endometrium from women with different outcomes following IVF. Molecular human reproduction MHR, 14(8), pp. 475-84. Oxford: Oxford University Press 10.1093/molehr/gan036
Wunder, Dorothea M; Guibourdenche, Jean; Birkhäuser, Martin H; Bersinger, Nick A (2008). Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertility and sterility, 90(6), pp. 2203-10. New York, N.Y.: Elsevier 10.1016/j.fertnstert.2007.10.078
Birkhäuser, M H; Panay, N; Archer, D F; Barlow, D; Burger, H; Gambacciani, M; Goldstein, S; Pinkerton, J A; Sturdee, D W (2008). Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric, 11(2), pp. 108-23. Abingdon, UK: Informa Healthcare 10.1080/13697130801983921
Pines, A; Sturdee, D W; Birkhauser, M H; de Villiers, T; Naftolin, F; Gompel, A; Farmer, R; Barlow, D; Tan, D; Maki, P; Lobo, R; Hodis, H (2008). HRT in the early menopause: scientific evidence and common perceptions. Climacteric, 11(4), pp. 267-72. Abingdon, UK: Informa Healthcare 10.1080/13697130802226866
Birkhäuser, M H; Reinecke, I (2008). Current trends in hormone replacement therapy: perceptions and usage. Climacteric, 11(3), pp. 192-200. Abingdon, UK: Informa Healthcare 10.1080/13697130802060455
Pines, Amos; Sturdee, David; Birkhäuser, Martin (2008). Health risks after cessation of postmenopausal hormone therapy. Climacteric, 11(3), pp. 179-80. Abingdon, UK: Informa Healthcare 10.1080/13697130802176228
Birkhauser, M; Braendle, W; Kiesel, L; Kuhl, H; Neulen, J; Thaler, C J (2008). [Recommendations for hormone treatment with estrogen and progesterone in the climacteric and postmenopausal periods. 37th Workshop of the Zurich Discussion Group , September 2006]. Gynäkologisch-geburtshilfliche Rundschau, 48(1), pp. 38-46. Basel: Karger
Birkhäuser, MH (2008). Östrogene zur Osteoporoseprävention. Was gilt 2008. Gynäkologie(1), pp. 2-6. Neuhausen (CH): Rosenfluh Publikationen
Pines, A; Sturdee, D; Birkhäuser, MH; de Villiers, T; Naftolin, F; Gompel, A; Farmer, R; Barlow, D; Tan, D; Maki, P; Lobo, R; Hordis, H (2008). Kongressbericht: HRT in der frühen Manopause: Wissenschaftliche Evidenz und allgemeine Wahrnehmung. Journal für gynäkologische Endokrinologie - Schweiz, 2(4), pp. 23-27. Gablitz (A): Krause & Pachernegg
Birkhäuser, MH (2008). Editorial. Gynäkologie(1), p. 1. Neuhausen (CH): Rosenfluh Publikationen
Birkhäuser, H (2008). Editorials. Journal für gynäkologische Endokrinologie - Schweiz, 2(1) Gablitz (A): Krause & Pachernegg
Bersinger, N A; Wunder, D M; Nicolas, M; Birkhäuser, M H; Porquet, D; Guibourdenche, J (2008). Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies. Fetal diagnosis and therapy, 24(1), pp. 74-8. Basel: Karger 10.1159/000132412
Kuhn, Annette; Hiltebrand, Rahel; Birkhäuser, Martin (2007). Do transsexuals have micturition disorders? European journal of obstetrics & gynecology and reproductive biology, 131(2), pp. 226-30. Shannon: Elsevier 10.1016/j.ejogrb.2006.03.019
Kohler, C; Tschumi, K; Bodmer, C; Schneiter, M; Birkhäuser, M (2007). Effect of finasterid 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testoerone. Gynecological endocrinology, 23(3), pp. 142-145. London: Informa Healthcare 10.1080/09513590701214463
Birkhäuser, MH; Brändle, W; Keller, PJ; Kiesel, L; Kuhl, H; Neulen, J (2007). Empfehlungen zur Substitution mit Östrogenen und Gestagenen im Klimakterium und in der Postmenopause. Gynäkologisch-geburtshilfliche Rundschau(47), pp. 45-48. Basel: Karger
Birkhäuser, MH; Brändle, W; Keller, PJ; Kieser, L; Kuhl, H; Neulen, J (2007). Empfehlungen zur hormonalen Kontrazeption. Gynäkologisch-geburtshilfliche Rundschau(47), pp. 94-98. Basel: Karger
Birkhäuser, MH; Brändle, W; Kiesel, L; Kuhl, H; Neulen, J; Thaler, CJ (2007). Empfehlungen zur Hormonbehandlung mit Östrogenen und Gestagenen im Klimakterium und in der Postmenopause. Gynäkologisch-geburtshilfliche Rundschau(48), pp. 38-46. Basel: Karger
Birkhäuser, MH (2007). Editorial. Journal für gynäkologische Endokrinologie - Schweiz, 1(1), pp. 4-7. Gablitz (A): Krause & Pachernegg
Birkhäuser, MH (2007). Editorial. Journal für Menopause (Ausgabe für die Schweiz), 14(1), pp. 4-5. Gablitz (A): Krause & Pachernegg
Crazzolara, SHC; Wunder, DM; Nägeli, E; Bodmer, C; Graf, S; Birkhäuser, MH (2007). Semen parameters in a fertile Swiss population. Swiss medical weekly(137), pp. 166-172. Muttenz: EMH Schweizerischer Ärzteverlag
Pines, A; Sturdee, D; Birkhäuser, MH; Gambacciani, M; Panay, N (2007). Empfehlungen zur postmenopausalen Hormontherapie. Journal für gynäkologische Endokrinologie - Schweiz, 1(1), pp. 18-20. Heidelberg: Krause & Pachernegg
Pines, A; Sturdee, D; Birkhäuser, MH; Gambacciani, M; Panay, N (2007). Reccommandations sur le traitement hormonal lors de la post-ménopause. Journal für gynäkologische Endokrinologie - Schweiz, 1(1), pp. 21-23. Heidelberg: Krause & Pachernegg
Pines, A; Sturdee, D; Birkhäuser, MH; Schneider, HP; Gambacciani M.Panay, N (2007). Reccommendations on postmenopausal hormone therapy. Climacteric, 10(3), pp. 181-194. Abingdon, UK: Informa Healthcare 10.1080/13697130701361657
Pines, A; Sturdee, D; Birkhäuser, M (2007). Press Statement Breast cancer and hormone therapy: a looking-glass mirror? Climacteric, 10(5), pp. 356-357. Abingdon, UK: Informa Healthcare 10.1080/13697130701607877
Pines, A; Sturdee, D; Birkhäuser, M (2007). Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited. Climacteric, 10(3), pp. 195-196. Abingdon, UK: Informa Healthcare 10.1080/13697130701401073
Pines, A; Sturdee, D; Birkhäuser, M (2007). IMS reaction to recent breast cancer data. Climacteric, 10(1), pp. 9-10. Abingdon, UK: Informa Healthcare 10.1080/13697130601182989
Schwitter, J; Kozerke, S; Bremerich, J; Balters, C; Attenhofer, JC; Birkhäuser, MH; Bösiger, P; Buser, P (2007). Oral administration of 17Beta-Estradiol over 3 months without Progestin co-administration does not improve coronary flow reserve in postmenopausal women: a randomized placebo-controlled cross-over MR Study. Journal of cardiovascular magnetic resonance, 9(4), pp. 665-672. Philadelphia, Pa.: Taylor & Francis 10.1080/10976640601138730
Wunder, DM; Bersinger, NA; Yared, M; Kretschmer, R; Birkhäuser, MH (2007). Statistically significant changes of anti-mullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertility and sterility, 89(4), pp. 927-933. New York, N.Y.: Elsevier 10.1016/j.fertnstert.2007.04.054
Bersinger, NA; Wunder, DM; birkhäuser, MH; Guibourdenche, J (2007). Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid. Clinica chimica acta, 384(1-2), pp. 174-175. Amsterdam: Elsevier 10.1016/j.cca.2007.05.011
Wunder, D M; Yared, M; Bersinger, N A; Widmer, D; Kretschmer, R; Birkhäuser, M H (2006). Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. European journal of endocrinology, 155(1), pp. 137-42. Bristol: BioScientifica Ltd. 10.1530/eje.1.02178
Popp, Albrecht W E; Bodmer, Christine; Senn, Christoph; Fuchs, Gaby; Kraenzlin, Marius E; Wyss, H; Birkhaeuser, Martin H; Lippuner, Kurt (2006). Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. Maturitas, 53(2), pp. 191-200. Amsterdam: Elsevier 10.1016/j.maturitas.2005.04.004
Bersinger, Nick A; Birkhäuser, Martin H; Wunder, Dorothea M (2006). Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecological endocrinology, 22(9), pp. 479-83. London: Informa Healthcare 10.1080/09537100600931316
Wunder, Dorothea M; Mueller, Michael D; Birkhäuser, Martin H; Bersinger, Nick A (2006). Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta obstetricia et gynecologica Scandinavica, 85(3), pp. 336-42. Oxford: Wiley-Blackwell 10.1080/00016340500501715
Milsom, I; Lete, I; Bjertnaes, A; Rokstad, K; Lindh, I; Gruber, C J; Birkhäuser, M H; Aubeny, E; Knudsen, T; Bastianelli, C (2006). Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Human reproduction, 21(9), pp. 2304-11. Oxford: Oxford University Press 10.1093/humrep/del162
Birkhäuser, M; Braendle, W; Keller, P J; Kiesel, L; Kuhl, H; Neulen, J (2006). [Recommendations for hormonal contraception. 34. Workshop of the "Zurich Discussion Circle", April 2005]. Gynäkologisch-geburtshilfliche Rundschau, 46(1-2), pp. 58-63. Basel: Karger
Birkhäuser, M; Braendle, W; Keller, P J; Kiesel, L; Kuhl, H; Neulen, J (2006). [Recommendations for estrogen and progesterone replacement in climacteric and postmenopause. 33. Workshop of the "Zurich Discussion Circle", October 2004]. Gynäkologisch-geburtshilfliche Rundschau, 46(1-2), pp. 53-7. Basel: Karger
Koeferl Puorger, U P S; Buergin, M; Wunder, D; Crazzolara, S; Birkhaeuser, M H (2006). Surplus embryos in Switzerland in 2003: legislation and availability of human embryos for research. Reproductive biomedicine online, 13(6), pp. 772-7. Oxford: Elsevier 10.1016/S1472-6483(10)61023-1
Hugues, JN; Cédrin-Durnerin, I; Howles, CM; FSH, OI Study Group; Amram, M; Angelini, A; Balen, A; Barbereau, D; Birkhauser, M; Boujenah, A; De Leo, V; De Placido, G; Dessole, S; Favrin, S; Ferrazi, E; Gay, C; Germond, M; Hedon, B; Hocke, C; Jolly, C; ... (2006). The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study. Human reproduction, 21(11), pp. 2817-22. Oxford: Oxford University Press 10.1093/humrep/del265
Pines, A; Sturdee, DW; Birkhäuser, M; International, Menopause Society (2006). WHI and breast cancer: a response to a recent publication from the WHI. Climacteric, 9(4), p. 244. Abingdon, UK: Informa Healthcare 10.1080/13697130600865790
Pines, A; Sturdee, DW; Birkhäuser, M; International, Menopause Society (2006). More data on hormone therapy and coronary artery disease: comments on recent publications from the WHI and Nurses' Study. Climacteric, 9(2), pp. 75-6. Abingdon, UK: Informa Healthcare 10.1080/13697130600655415
Birkhäuser, MH (2006). Die klinische Bedeutung von Gestagen-Partialwirkungen Gynäkologischer Endokrinologie. Gynecological endocrinology(4), pp. 42-64. London: Informa Healthcare
Birkhäuser, MH (2006). Differenzierte HRT - wo stehen wir heute? Journal für Menopause (Ausgabe für die Schweiz), pp. 1-23. Gablitz (A): Krause & Pachernegg
Birkhäuser, MH (2006). Hormonersatztherapie nach WHI and Million Women Study. Gynäkologie + Geburtshilfe, pp. 41-42. Heidelberg: Springer-Medizin-Verlag
Pines, A; Sturdee, D; Birkhäuser, MH (2006). Hormonersatztherapie - Stellungnahme der Internationalen Menopausengesellschaft. Journal für Menopause (Ausgabe für die Schweiz)(1), pp. 21-22. Gablitz (A): Krause & Pachernegg
Stevenson, JC; Birkhäuser, MH; Burger, H; Brincat, M; Gaspard, U (2006). EMEA and Osteoporosis. Human reproduction(21), pp. 1668-1671. Oxford: Oxford University Press
Birkhäuser, Martin (2006). Clinical significance of partial gestagen effects. Gynäkologische Endokrinologie, 4(1), pp. 52-64. Springer-Medizin-Verlag 10.1007/s10304-006-0139-8
Birkhäuser, MH (2005). Was bedeuten die Resultate der Women's-Health-Initiative zur Hormonersatztherapie für die tägliche klinische Arbeit? Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(5), pp. 379-388. Basel: EMH Editores Medicorum Helveticorum
Wunder, D.M.; Limoni, C.; Birkhäuser, M.H. (2005). Lack of seasonal variations in fertilization, pregnancy and implantation rates in women undergoing IVF. Human reproduction, 20(11), pp. 3122-3129. Oxford University Press 10.1093/humrep/dei177
Wunder, Dorothea M.; Mueller, Michael D.; Birkhäuser, Martin H.; Bersinger, Nick A. (2005). Steroids and protein markers in the follicular fluid as indicators of oocyte quality in patients with and without endometriosis. Journal of assisted reproduction and genetics, 22(6), pp. 257-264. Springer 10.1007/s10815-005-5149-2
Bersinger, N.A.; Meisser, A.; Bessou, T.; Seguin, P.; Birkhäuser, M.H.; Bischof, P. (1999). Production and characterization of monoclonal antibodies against pregnancy-associated plasma protein A. Molecular human reproduction MHR, 5(7), pp. 675-681. Oxford University Press 10.1093/molehr/5.7.675
Berger, E.; Chabloz, P.; De Quay, N.; Sann, A.; Walton, S.; Germond, M.; Birkhäuser, M. (1999). O-112. An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum β 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF/ICSI treatment. Human reproduction, 14(Suppl 3), pp. 61-62. Oxford University Press 10.1093/humrep/14.Suppl_3.61-a
Bersinger, N A; Brandenberger, A; Berger, E; Baumann, C K; Birkhäuser, M H (1998). Serum pregnancy-specific beta1-glycoprotein before embryo transfer is related to endometrial thickness and to outcome prognosis in women undergoing in-vitro fertilization treatment. Human reproduction, 13(7), pp. 1962-1967. Oxford University Press 10.1093/humrep/13.7.1962
Brandenberger, Alfred W.; Bersinger, Nicolas A.; Huber, Peter R.; Berger, Elisabeth; Glanzmann, Patrick; Birkhäuser, Martin (1998). CA-125 Concentrations in the Serum and Pregnancy Outcome in IVF Cycles. Journal of assisted reproduction and genetics, 15(6), pp. 390-394. Springer 10.1023/A:1022589101648
Bersinger, N.A.; Brandenberger, A.; Birkhäuser, M.H. (1997). O-114. The presence of pregnancy-specific β1-glycoprotein in serum before embryo transfer is associated with lower endometrial thickness and poor pregnancy prognosis in IVF. Human reproduction, 12(Suppl 2), pp. 54-55. Oxford University Press 10.1093/humrep/12.Suppl_2.54-a
Bersinger, N.A.; Senn, A.; Chanson, A.; Germond, M.; Birkhäuser, M.H.; De Grandi, P. (1997). P-220. Significance of non-placental pregnancy-specific α1-glycoprotein in the serum of IVF cycles before and after embryo transfer. Human reproduction, 12(Suppl 2), p. 222. Oxford University Press 10.1093/humrep/12.Suppl_2.222
Berger, E.; Zakher, S.; Mueller, M.D.; Glanzman, P.; Brandenberger, A.; Bersinger, N.A.; Birkhäuser, M.H. (1997). R-044. Limiting the number of embryos transferred does not significantly influence the outcome of conventional IVF treatment. Human reproduction, 12(Suppl 2), pp. 255-256. Oxford University Press 10.1093/humrep/12.Suppl_2.255-b
Bersinger, N.A.; Brandenberger, A.W.; Birkhäuser, M.H. (1995). Implantation: Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilization cycles. Human reproduction, 10(8), pp. 2149-2154. Oxford University Press 10.1093/oxfordjournals.humrep.a136251
Birkhäuser, MH; Kuhl, H; Mück, O; Schaudig, K; Dierks, C (2008). 2008. Tinneberg: Commed Verlag
Tinneberg, HR; Birkhäuser, HM; Kuhl, K; Mueck, AO; Schaudig, K; Dierks, C (2007). Aktuelles zur Hormonersatztherapie. ComMed Update 2007
Rohner, S; Birkhäuser, M; Santi, A; Mueller, MD; Kuhn, A (2012). Gynäkologische Probleme bei Transsexuellen: eine Analyse von 1956 Konsultationen. In: Jahreskongress SGGG , Interlaken 2012. Jahreskongress SGGG , Interlaken 2012
Villena Ossa, T; Kuhn, A; Burckhardt, I; Bodmer, Ch; Birkhäuser, M (2011). Sexuelle Orientierung transsexuelle Patienten. In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011
Wunder, D; Birkhäuser, MH; Bersinger, NA (2011). Soluble HLA-G concentration in follicular fluid and embryo culture medium and its impact on prediction or pregnancy. In: Jahreskongress SGGG, Lugano 2011 28 (pp. 43-50). Jahreskongress SGGG, Lugano 2011 10.1016/j.immbio.2012.10.004
Wunder, D; Neurohr, EM; Faouzi, M; Birkhäuser, M (2011). Origin of multiple pregnancies in Berne, Switzerland, between 1995 and 2006: is IVF-ICSI really the most important origin? In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011
